Previous evidence about the effects of lowering cholesterol in people with diabetes has been limited, and most diabetic patients do not currently receive cholesterol-lowering therapy despite their increased risk. Methods: 5963 UK adults (aged 40-80 years) known to have diabetes, and an additional ...
Trust someone who had a heart attack 5 years ago and has obsessed about cardiac science and diet ever since. Statins are not bad per se, the best thing about them is that they reduce arterial inflammation, the cholesterol lowering is by the by really. I take them (maximum dose) and no ...
If the amount of cholesterol or other fat in your blood has increased because of your anti-HIV treatment you might be advised to switch treatments, be given cholesterol-lowering medication, or both. Diagnosis and monitoring High cholesterol doesn’t usually cause any symptoms, so it’s important...
Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360: 7-22. PMID: 12114036MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in ...
MRC/BHF Heart Protection Study Collaborative Group 1999 MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experiences. Eur Heart J 20:725-...
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial.Summary Background Throughout the usual LDL cholesterol range in Western populations, lower blood concentrations are associated with lower cardiovascular disease ...
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.EnzymeOxidoreductasesStatin derivativeHumanPlaceboControlled environment studyRandomizationHydroxymethylglutaryl-CoA reductase...
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.doi:10.1016/S1062-1458(02)00911-XingentaconnectACC Current Journal Review
Articles MRC / BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes : a randomised placebo- controlled trialProtection, HeartCollaborative, Study
MRC/BHF Heart Protection Study of cholesterol- lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005-2016.Collins R, Armitage J, Parish S, Sleigh P, Peto R; Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study ...